posted
Lifestream Technologies Signs Agreement With Polymer for New Cholesterol/HDL Test Tuesday December 13, 6:30 am ET Lifestream to Bring a New Cholesterol/HDL Test to Market POST FALLS, Idaho--(BUSINESS WIRE)--Dec. 13, 2005--Lifestream Technologies, Inc. (OTCBB:LFTC - News), a leading supplier of cholesterol monitors, announced today that it has entered into an agreement with Polymer Technology Systems, Inc., for supply of test strips for its new Cholesterol/HDL monitor.
"We are pleased that Lifestream and Polymer will collaborate to bring consumers the ability to measure not only total cholesterol but also HDL cholesterol," said Christopher Maus, Lifestream's CEO. "Now, those who know both their total and HDL cholesterol can determine if they have a ratio that increases or decreases their risk for coronary heart disease. The addition of this important test will complement our present product and expand our market opportunities." The supply relationship with Polymer meets the stringent quality standards required by Lifestream and provides the Company with a very competitive price. Requested by consumers and pharmacists alike, the HDL cholesterol test will give consumers an additional tool in monitoring their risk for heart disease. The Cholesterol:HDL ratio is a better indicator of the number one cause of death, heart disease, than cholesterol alone. Consumer awareness for cholesterol testing and heart disease can be significantly increased with the addition of this new chemistry. "Polymer is pleased to be partnering with Lifestream on this project," stated Robert S. Huffstodt, Polymer's CEO. "This agreement is beneficial for both companies, and expands the choices for the health conscious consumer. The ability to perform both tests with one analyzer is more cost effective for the consumer and allows them to monitor two risk factors important in preventing or managing heart disease."
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
